Methods of treating or preventing tissue damage caused by increased blood flow

Details for Australian Patent Application No. 2007207609 (hide)

Owner Regenerx Biopharmaceuticals, Inc.

Inventors Finkelstein, J.J.; Goldstein, Allan L.

Agent Wrays

Pub. Number AU-B-2007207609

PCT Pub. Number WO2007/084544

Priority 60/759,051 17.01.06 US

Filing date 17 January 2007

Wipo publication date 26 July 2007

Acceptance publication date 4 October 2012

International Classifications

A61K 38/32 Medicinal preparations containing peptides - Thymopoietins

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

31 July 2008 PCT application entered the National Phase

  PCT publication WO2007/084544 Priority application(s): WO2007/084544

4 October 2012 Application Accepted

  Published as AU-B-2007207609

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007207612-Endoluminal delivery device

2007207607-Treatment of inflammatory disorders with triazole compounds